Drug class in one race
NPC1L1 drugs for Atherosclerotic Cardiovascular Disease
2 tracked NPC1L1 drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the NPC1L1 page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.
2 Phase 3
Head-to-head evidence: Ezetimibe vs Hyzetimibe